Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-16-141569
Filing Date
2016-09-15
Accepted
2016-09-15 16:03:28
Documents
1
Period of Report
2016-09-14

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3105
  Complete submission text file 0001209191-16-141569.txt   4452
Mailing Address C/O SPRING BANK PHARMACEUTICALS, INC. STE S-7 MILFORD MA 01757
Business Address
Eichler Kurt M (Reporting) CIK: 0001424591 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37718 | Film No.: 161887230

Mailing Address 86 SOUTH STREET HOPKINTON MA 01748
Business Address 86 SOUTH STREET HOPKINTON MA 01748 508-473-5993 X119
Spring Bank Pharmaceuticals, Inc. (Issuer) CIK: 0001566373 (see all company filings)

EIN.: 522386345 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations